No abstract

Our results indicate that pruritus, xerosis and erythema are common adverse cutaneous reactions to facial skin care products. These reactions vary with age, but not with sex. Vigorous safety testing should precede the marketing of skin care products.

Background Mesenchymal stem cells‐derived exosome (MSCs‐exo) was identified to reduce photoaging. The purpose of this study was to investigate the potential role of microRNA (miR)‐29b‐3p derived from bone marrow MSCs‐exo (BMSCs‐exo) in photoaging. Methods Exosomes were isolated from BMSCs and verified by Western blot. A photoaging cell model was constructed by UVB irradiation of human dermal fibroblasts (HDFs). Quantitative real‐time PCR (RT‐qPCR) was performed to detect the mRNA levels of miR‐29b‐3p, collagen type I and matrix metalloproteinases (MMPs). CCK‐8, Transwell and flow cytometry were applicated to examine cell viability, migration and apoptosis. Commercial kits are used to measure levels of oxidative stress indicators. Finally, a dual‐luciferase reporter assay was applied to validate the target of miR‐29b‐3p. Results Extracted exosomes were positive for HSP70 and CD9. Survival of HDFs increased in an exosome concentration‐dependent manner. UVB irradiation inhibited miR‐29b‐3p levels compared with controls, but BMSCs‐exo treatment restored miR‐29b‐3p levels (p < .05). Additionally, BMSCs‐exo‐miR‐29b‐3p reversed the inhibition of HDFs migration and oxidative stress by UVB irradiation, as well as the promotion of apoptosis. However, this reversal was attenuated by the suppression of miR‐29b‐3p (p < .05). Furthermore, BMSCs‐exo‐miR‐29b‐3p also inhibited the degradation of collagen type I and the production of MMPs in photoaging, and they were also eliminated by the reduced miR‐29b‐3p. Finally, MMP‐2 was the target gene of miR‐29b‐3p. Conclusion Our study presented a novel role for BMSCs‐exo‐miR‐29b‐3p in improving skin photoaging function, and these findings may provide new insights into the targeted treatment of skin photoaging.

is manifested by either ipsilateral or bilateral pigmented patch with or without hypertrichosis. Although other regimens, including oral antiandrogen and topical glycolic acid, are available, lasers are the most widely used therapeutic regimen.

No abstract